ZA963826B - A method of treatment of mania and bipolar disorder - Google Patents

A method of treatment of mania and bipolar disorder

Info

Publication number: ZA963826B
Authority: ZA; South Africa
Prior art keywords: treatment; mania; bipolar disorder; gabapentin; recurrent
Prior art date: 1995-05-15

Application number

ZA963826A

Other languages

English (en)

Inventor

Atul Chandra Pande

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-15

Filing date

1996-05-14

Publication date

1996-11-21

1996-05-14 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1996-11-21 Publication of ZA963826B publication Critical patent/ZA963826B/xx

Links

208000020925 Bipolar disease Diseases 0.000 title abstract 2
206010026749 Mania Diseases 0.000 title abstract 2
UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 abstract 2
230000001154 acute effect Effects 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229960002870 gabapentin Drugs 0.000 abstract 1
230000000306 recurrent effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Beans For Foods Or Fodder (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pyridine Compounds (AREA)
Saccharide Compounds (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA963826A 1995-05-15 1996-05-14 A method of treatment of mania and bipolar disorder ZA963826B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/440,570 US5510381A (en)	1995-05-15	1995-05-15	Method of treatment of mania and bipolar disorder

Publications (1)

Publication Number	Publication Date
ZA963826B true ZA963826B (en)	1996-11-21

Family

ID=23749281

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA963826A ZA963826B (en)	1995-05-15	1996-05-14	A method of treatment of mania and bipolar disorder

Country Status (19)

Country	Link
US (1)	US5510381A (de)
EP (1)	EP0825857B1 (de)
JP (1)	JPH11505244A (de)
AT (1)	ATE218857T1 (de)
AU (1)	AU702435B2 (de)
CA (1)	CA2215923C (de)
CZ (1)	CZ288072B6 (de)
DE (1)	DE69621799T2 (de)
DK (1)	DK0825857T3 (de)
EE (1)	EE03420B1 (de)
ES (1)	ES2177783T3 (de)
GE (1)	GEP20002014B (de)
HU (1)	HUP9802087A3 (de)
NO (1)	NO315967B1 (de)
NZ (1)	NZ307366A (de)
PT (1)	PT825857E (de)
SK (1)	SK281982B6 (de)
WO (1)	WO1996036328A1 (de)
ZA (1)	ZA963826B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6372792B1 (en)	1996-04-26	2002-04-16	Guy Chouinard	Method for treating anxiety, anxiety disorders and insomnia
US6001876A (en)	1996-07-24	1999-12-14	Warner-Lambert Company	Isobutylgaba and its derivatives for the treatment of pain
WO1999018063A2 (en)	1997-10-07	1999-04-15	Warner-Lambert Company	Process for preparing a cyclic amino acid anticonvulsant compound
KR100589066B1 (ko)	1997-10-27	2006-06-13	워너-램버트 캄파니 엘엘씨	약제로서 유용한 시클릭 아미노산 및 그의 유도체
PL205145B1 (pl) *	1998-05-15	2010-03-31	Warner Lambert Co	Trwała kompozycja stała zawierająca pochodną 4-amino-3-podstawionego kwasu butanowego oraz sposób jej wytwarzania
IL139298A0 (en)	1998-05-15	2001-11-25	Warner Lambert Co	Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
EP1082306A1 (de)	1998-05-26	2001-03-14	Warner-Lambert Company	Aminosäureverbindungen mit starrer konformation mit affinität für die alpha2delta untereinheit eines calciumkanals
US6306910B1 (en) *	1998-07-09	2001-10-23	Warner-Lambert Company	Use of Gaba-analogues for treating insomnia
KR100697734B1 (ko) *	1998-10-16	2007-03-22	워너-램버트 캄파니 엘엘씨	조증 및 양극성 장애 치료용 제약 조성물
ES2185591T3 (es) *	1999-06-02	2003-05-01	Warner Lambert Co	Amino hererociclos utiles como agentes farmaceuticos.
AP2002002501A0 (en) *	1999-10-07	2002-06-30	Warner Lambert Co	Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
AU2001266992B8 (en) *	2000-06-16	2005-12-01	Teva Pharmaceutical Industries Ltd.	Stable gabapentin having pH within a controlled range
ATE390133T1 (de) *	2000-06-26	2008-04-15	Warner Lambert Co	Gabapentinanaloga für schlafstörungen
US20030119908A1 (en) *	2001-12-21	2003-06-26	Zambon Group S.P.A.	Stable gabapentin compositions
ITMI20012750A1 (it)	2001-12-21	2003-06-21	Procos Spa	Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
US20130078290A1 (en)	2010-06-01	2013-03-28	Rubicon Research Private Limited	Gastroretentive Dosage Forms Of GABA Analogs
WO2015144825A1 (en)	2014-03-27	2015-10-01	Sanovel Ilac Sanayi Ve Ticaret A.S.	Oral liquid pharmaceutical solution of gabapentin
US11670410B1 (en) *	2022-04-13	2023-06-06	Green Sky Creations LLC	Systems and methods to automatically administer a psychoactive substance to an airway of a user based on a detected event or condition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2460891C2 (de) *	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) *	1974-12-21	1978-05-02	Warner-Lambert Company	Treatment of cranial dysfunctions using novel cyclic amino acids
US4355044A (en) *	1980-12-19	1982-10-19	Bernardo Heller	D-Phenylalanine treatment
US5084479A (en) *	1990-01-02	1992-01-28	Warner-Lambert Company	Novel methods for treating neurodegenerative diseases
US5086072A (en) *	1990-06-18	1992-02-04	The United States Of America As Represented By The Department Of Health And Human Services	Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
US5025035A (en) *	1990-10-12	1991-06-18	Warner-Lambert Company	Method of treating depression

1995
- 1995-05-15 US US08/440,570 patent/US5510381A/en not_active Expired - Fee Related
1996
- 1996-04-26 AU AU56689/96A patent/AU702435B2/en not_active Ceased
- 1996-04-26 CA CA002215923A patent/CA2215923C/en not_active Expired - Fee Related
- 1996-04-26 CZ CZ19973558A patent/CZ288072B6/cs not_active IP Right Cessation
- 1996-04-26 DK DK96913852T patent/DK0825857T3/da active
- 1996-04-26 HU HU9802087A patent/HUP9802087A3/hu unknown
- 1996-04-26 PT PT96913852T patent/PT825857E/pt unknown
- 1996-04-26 NZ NZ307366A patent/NZ307366A/en unknown
- 1996-04-26 EP EP96913852A patent/EP0825857B1/de not_active Expired - Lifetime
- 1996-04-26 WO PCT/US1996/005898 patent/WO1996036328A1/en not_active Ceased
- 1996-04-26 ES ES96913852T patent/ES2177783T3/es not_active Expired - Lifetime
- 1996-04-26 GE GEAP19964027A patent/GEP20002014B/en unknown
- 1996-04-26 AT AT96913852T patent/ATE218857T1/de not_active IP Right Cessation
- 1996-04-26 EE EE9700302A patent/EE03420B1/xx not_active IP Right Cessation
- 1996-04-26 SK SK1528-97A patent/SK281982B6/sk unknown
- 1996-04-26 DE DE69621799T patent/DE69621799T2/de not_active Expired - Fee Related
- 1996-04-26 JP JP8534854A patent/JPH11505244A/ja not_active Ceased
- 1996-05-14 ZA ZA963826A patent/ZA963826B/xx unknown
1997
- 1997-11-14 NO NO19975234A patent/NO315967B1/no unknown

Also Published As

Publication number	Publication date
CZ288072B6 (cs)	2001-04-11
SK152897A3 (en)	1999-05-07
EP0825857A1 (de)	1998-03-04
EP0825857B1 (de)	2002-06-12
MX9707269A (es)	1997-11-29
PT825857E (pt)	2002-11-29
EE03420B1 (et)	2001-06-15
AU5668996A (en)	1996-11-29
ATE218857T1 (de)	2002-06-15
HUP9802087A3 (en)	1999-08-30
ES2177783T3 (es)	2002-12-16
HUP9802087A2 (hu)	1998-12-28
CA2215923C (en)	2001-10-09
CZ355897A3 (cs)	1998-02-18
NO975234D0 (no)	1997-11-14
GEP20002014B (en)	2000-04-10
EE9700302A (et)	1998-06-15
CA2215923A1 (en)	1996-11-21
SK281982B6 (sk)	2001-09-11
AU702435B2 (en)	1999-02-18
DE69621799T2 (de)	2003-01-02
WO1996036328A1 (en)	1996-11-21
US5510381A (en)	1996-04-23
NO315967B1 (no)	2003-11-24
NZ307366A (en)	1999-10-28
DK0825857T3 (da)	2002-09-30
DE69621799D1 (de)	2002-07-18
JPH11505244A (ja)	1999-05-18
NO975234L (no)	1997-11-14

Publication	Publication Date	Title
CA2344407A1 (en)	2000-04-27	Method for the treatment of mania and bipolar disorder
EE9700302A (et)	1998-06-15	Meetod maania ja bipolaarse häire raviks
HUS1300046I1 (hu)	2016-08-29	Izobutil-gaba és származékai alkalmazása fájdalom kezelésére alkalmas gyógyszer elõállítására
CA2258895A1 (en)	1998-01-08	Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
ID28003A (id)	2001-05-03	Turunan-turunan adamantana
DE69112895D1 (de)	1995-10-19	Pharmazeutische Verbindungen.
AU6256996A (en)	1996-12-30	Use of vitamin D4 derivatives for treating skin disorders
CA2387873A1 (en)	2001-04-26	Nordihydroguaiaretic derivatives for use in treatment of tumors
EP0347864A3 (de)	1992-04-01	Antiatherosklerose-Mittel
ATE275966T1 (de)	2004-10-15	Activin stimulator enthaltende pharmazeutische zusammensetzung
YU42298A (sh)	1999-09-27	Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
CA2135709A1 (en)	1995-05-19	Melatonin derivatives for use in treating sleep disorders
WO1998022099A3 (en)	1998-07-09	New use of creatine
WO1997005864A3 (en)	1997-04-17	Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
ZA963744B (en)	1996-11-21	Topical aciclovir preparation
PL328948A1 (en)	1999-03-01	Autism treating method
SI0797997T1 (en)	2005-10-31	Use of peptidic bradykinin antagonists for the preparation of medicaments
NO953003L (no)	1996-01-30	Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
BR9801839A (pt)	2000-01-18	Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
ZA977004B (en)	1998-08-06	Therapeutic product and its use
MX9801515A (es)	1998-08-30	Preparado de combinacion para la aplicacion en la demencia.
YU40098A (sh)	1999-09-27	Upotreba olanzapina za dobijanje leka
SI0825857T1 (en)	2002-10-31	Use of gabapentin and its derivatives in the treatment of mania and bipolar disorder
ZA977895B (en)	1998-03-02	Transdermal therapeutic system having an active compound combination comprising oestriol.